68 Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer.
Davies A, Foo M, Gan CL, Kourambas J, Redgrave N, Donnellan S, Appu S, Williams S, Coleman A, Segelov E, Bradley J, Soo G, Ramdave S, Kwan EM, Azad AA.
Davies A, et al.
Asia Pac J Clin Oncol. 2022 Oct;18(5):e204-e210. doi: 10.1111/ajco.13595. Epub 2021 Jun 23.
Asia Pac J Clin Oncol. 2022.
PMID: 34161628